首頁 > 市場調查報告書 > 製藥

生物製劑分子標靶治療學

市場調查報告書

商品編碼

1547870

全球單株抗體市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Monoclonal Antibodies Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球單株抗體市場需求預計將從2023年的2,386.1億美元達到2032年近6,088.8億美元的市場規模，2024-2032年研究期間的複合年成長率為10.97%。

單株抗體是相同的免疫球蛋白，由單一 B 細胞克隆產生。它是一種古老的免疫學工具，應用於生物化學、免疫學、生物技術和應用生物學領域。這些是由人體免疫系統對細菌、真菌、寄生蟲、病毒、化學物質和其他物質等抗原作出反應而產生的。科學家在實驗室中生產抗體來模仿免疫系統的作用，借助免疫療法來治療疾病。單株抗體通常透過注射施用。

市場動態

單株抗體的生產是實驗室研究的古老做法。其在臨床醫學領域有廣泛的應用。全球實驗室的研究揭示了不同科學分支的其他應用。對新療法的不斷探索正在推動市場的成長。人們對抗體產品開發的持續興趣是由分子層面上疾病的快速發展和理解所驅動的。由於其高度特異性，單株抗體對於理解基礎免疫學和分子研究非常有價值。單株抗體擴大用於研究和診斷、癌症和免疫疾病的治療工具以及製藥等應用，從而在行業中產生了巨大的需求。目前，單株抗體佔白血病、關節炎、乳癌和移植的所有新療法的三分之一，它們在疾病預測和檢測中的作用帶來了希望。世界各地的科學家都在尋找 COVID-19 的治療方法。正在進行的研究表明，單株抗體可以治療甚至預防 COVID-19，並有望成為市場的下一個重大產品。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球單株抗體市場的各個細分市場進行了包容性評估。單株抗體產業的成長和趨勢為本研究提供了整體方法。

市場區隔

單株抗體市場報告的這一部分提供了國家和區域層級細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標群體以及即將到來的機會。

按來源類型

鼠類
嵌合體
人性化
人類

按生產類型

體內
體外

按申請

腫瘤學
自體免疫疾病
傳染病
神經系統疾病
其他

按最終用途

醫院
專科中心
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲單株抗體市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。單株抗體市場的主要參與者包括諾華公司、輝瑞公司、葛蘭素史克公司、安進公司、默克公司、第一三共有限公司、雅培實驗室、阿斯特捷利康公司、禮來公司、強生服務公司公司。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按來源類型分類的市場吸引力分析
- 按生產類型分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球單株抗體市場分析：依來源類型

按來源類型概述
歷史和預測數據
按來源類型分析
鼠類
嵌合體
人性化
人類

第 6 章：全球單株抗體市場分析：依生產類型

按生產類型概述
歷史和預測數據
按生產類型分析
體內
體外

第 7 章：全球單株抗體市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
腫瘤學
自體免疫疾病
傳染病
神經系統疾病
其他

第 8 章：全球單株抗體市場分析：依最終用途分類

按最終用途分類的概述
歷史和預測數據
按最終用途分析
醫院
專科中心
其他

第 9 章：全球單株抗體市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：單株抗體公司的競爭格局

單株抗體市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Novartis AG

公司概況
公司收入
產品
最新動態

Pfizer Inc

公司概況
公司收入
產品
最新動態

GlaxoSmithKline Plc

公司概況
公司收入
產品
最新動態

Amgen Inc.

公司概況
公司收入
產品
最新動態

Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Daiichi Sankyo Company

公司概況
公司收入
產品
最新動態

Limited

公司概況
公司收入
產品
最新動態

Abbott Laboratories

公司概況
公司收入
產品
最新動態

AstraZeneca Plc

公司概況
公司收入
產品
最新動態

Eli Lilly And Company

公司概況
公司收入
產品
最新動態

Johnson & Johnson Services Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212693

The global demand for Monoclonal Antibodies Market is presumed to reach the market size of nearly USD 608.88 Billion by 2032 from USD 238.61 Billion in 2023 with a CAGR of 10.97% under the study period 2024-2032.

Monoclonal antibodies are identical immunoglobulins, generated from a single B-cell clone. It is an old immunological tool with applications in the fields of biochemistry, immunology, biotechnology, and applied biology. These are produced by the body's immune system in response to antigens such as bacteria, fungi, parasites, viruses, chemicals, and other substances. Scientists produce antibodies in the lab to mimic the action of the immune system to treat diseases with the help of immunotherapy. Monoclonal antibodies are generally administered by injection.

MARKET DYNAMICS

Production of monoclonal antibodies is an old practice in laboratory research. It is widely applied in the field of clinical medicine. Research from the laboratory globally is revealing additional applications in diverse branches of sciences. Growing search for new therapeutics is propelling the growth of the market. The continued interest in antibody product development is driven by the rapid advancement and understanding of disease at a molecular level. MAbs are extremely valuable for understanding basic immunological and molecular research due to their high specificity. MAbs are increasingly used for applications such as research and diagnosis, therapeutic tools in cancer and immunological disorders, and pharmacy, thus generating a great demand in the industry. Currently, MAbs account for one-third of all the new treatments for leukaemia, arthritis, breast cancer, and transplant, their role in disease prediction and detection offers promise. Scientist all over the world is looking for COVID-19 treatment. Ongoing research says that monoclonal antibodies could treat or even prevent COVID-19 and could promise as the next big thing for market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Monoclonal Antibodies. The growth and trends of Monoclonal Antibodies industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Monoclonal Antibodies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source Type

Murine
Chimeric
Humanized
Human

By Production Type

In Vivo
In Vitro

By Application

Oncology
Autoimmune Diseases
Infectious Diseases
Neurological Diseases
Others

By End-use

Hospitals
Specialty Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Monoclonal Antibodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Monoclonal Antibodies market include Novartis AG, Pfizer Inc, GlaxoSmithKline Plc, Amgen Inc., Merck & Co. Inc., Daiichi Sankyo Company, Limited, Abbott Laboratories, AstraZeneca Plc, Eli Lilly And Company, Johnson & Johnson Services Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MONOCLONAL ANTIBODIES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Source Type
- 3.7.2 Market Attractiveness Analysis By Production Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY SOURCE TYPE

5.1. Overview By Source Type
5.2. Historical and Forecast Data
5.3. Analysis By Source Type
5.4. Murine Historic and Forecast Sales By Regions
5.5. Chimeric Historic and Forecast Sales By Regions
5.6. Humanized Historic and Forecast Sales By Regions
5.7. Human Historic and Forecast Sales By Regions

6. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY PRODUCTION TYPE

6.1. Overview By Production Type
6.2. Historical and Forecast Data
6.3. Analysis By Production Type
6.4. In Vivo Historic and Forecast Sales By Regions
6.5. In Vitro Historic and Forecast Sales By Regions

7. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Oncology Historic and Forecast Sales By Regions
7.5. Autoimmune Diseases Historic and Forecast Sales By Regions
7.6. Infectious Diseases Historic and Forecast Sales By Regions
7.7. Neurological Diseases Historic and Forecast Sales By Regions
7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Specialty Centers Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE MONOCLONAL ANTIBODIES COMPANIES

10.1. Monoclonal Antibodies Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF MONOCLONAL ANTIBODIES INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Novartis AG
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Pfizer Inc
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GlaxoSmithKline Plc
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Amgen Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Merck & Co. Inc.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Daiichi Sankyo Company
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Limited
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Abbott Laboratories
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. AstraZeneca Plc
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Eli Lilly And Company
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Johnson & Johnson Services Inc
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments